Sarepta Therapeutics, Inc. (SRPT) financial statements (2021 and earlier)

Company profile

Business Address 215 FIRST STREET
CAMBRIDGE, MA 02142
State of Incorp. DE
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments, including:1,9481,1341,1751,090329204211
Cash and cash equivalents1,5038353716001228074
Short-term investments436290803479195112137
Other undisclosed cash, cash equivalents, and short-term investments91011111121
Restricted cash and investments    1111 
Receivables101914929542
Inventory, net of allowances, customer advances and progress billings2321711258413  
Inventory2321711258413  
Prepaid expense      3
Deposits current assets      31
Other current assets213827837271735
Other undisclosed current assets(9)(10)(1)(11)(11)(12)(34)
Total current assets:2,4851,4691,4261,229373225248
Noncurrent Assets
Operating lease, right-of-use asset9238
Property, plant and equipment1901309743383739
Long-term investments and receivables   10   
Long-term investments   10   
Intangible assets, net (including goodwill)14121214876
Intangible assets, net (excluding goodwill)14121214876
Prepaid expense  87   
Regulated entity, other noncurrent assets   1   
Deposits noncurrent assets  63    
Restricted cash and investments  11111
Other noncurrent assets204174  442
Other undisclosed noncurrent assets  363   
Total noncurrent assets:50035421679514947
TOTAL ASSETS:2,9851,8231,6421,308424274295
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities30525416877614936
Accounts payable11168348302012
Accrued liabilities19418613469312917
Employee-related liabilities      6
Deferred revenue89 
Debt   61080
Deferred revenue and credits3333
Contract with customer, liability3
Other liabilities221121111
Other undisclosed current liabilities      (4)
Total current liabilities:41626517488756237
Noncurrent Liabilities
Long-term debt and lease obligation1,0737304214256151
Long-term debt, excluding current maturities9926824214256151
Operating lease, liability8048
Liabilities, other than long-term debt68310166667
Deferred revenue and credits   7
Deferred revenue663 
Other liabilities201016666 
Other undisclosed noncurrent liabilities51     2
Total noncurrent liabilities:1,807740436430122111
Total liabilities:2,2231,005610519878347
Stockholders' equity
Stockholders' equity attributable to parent7628181,032789337190248
Common stock0000000
Additional paid in capital3,6103,1122,6112,0071,5031,090927
Accumulated other comprehensive income (loss)00(0)(0)(0)(0)(0)
Accumulated deficit(2,848)(2,294)(1,579)(1,217)(1,166)(899)(679)
Total stockholders' equity:7628181,032789337190248
TOTAL LIABILITIES AND EQUITY:2,9851,8231,6421,308424274295

Income statement (P&L) ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Revenues5403813011555110
Revenue, net1555110
Cost of revenue(171)(67)(30)(32)(0)  
Cost of goods and services sold    (0)  
Gross profit:3693142711235110
Operating expenses(933)(1,020)(614)(294)(272)(221)(144)
Operating loss:(564)(706)(344)(172)(267)(220)(134)
Nonoperating income (expense)11(8)(19)123(1)0(2)
Investment income, nonoperating3772   
Other nonoperating income (expense)1(0)(1)(2)(1)01
Interest and debt expense(60)(31)(2)(6)  (0)
Loss from continuing operations before equity method investments, income taxes:(613)(745)(365)(54)(267)(220)(136)
Other undisclosed income from continuing operations before income taxes603126   
Loss from continuing operations before income taxes:(553)(714)(363)(49)(267)(220)(136)
Income tax expense (benefit)(1)(1)1(2)   
Net loss:(554)(715)(362)(51)(267)(220)(136)
Other undisclosed net income attributable to parent      0
Net loss available to common stockholders, diluted:(554)(715)(362)(51)(267)(220)(136)

Comprehensive Income ($ in millions)

12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
Net loss:(554)(715)(362)(51)(267)(220)(136)
Other comprehensive income (loss)(0)00(0)(0)(0)(0)
Comprehensive loss:(554)(715)(362)(51)(267)(220)(136)
Other undisclosed comprehensive income, net of tax, attributable to parent      0
Comprehensive loss, net of tax, attributable to parent:(554)(715)(362)(51)(267)(220)(136)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: